Stampacchia Otello 4

What Happened

• Otello Stampacchia, a director of ImageneBio, was granted 15,600 shares (reported as a derivative award) on 2026-06-16 at an acquisition price of $0.00, for a reported total value of $0. This is an equity award (not an open-market purchase or sale) and is typically part of compensation or board director equity.

Key Details

• Transaction date and price: 2026-06-16, 15,600 shares at $0.00 per share.
• Total reported value: $0 (award/derivative grant).
• Shares owned after transaction: not disclosed on this Form 4.
• Vesting / footnote: The shares vest in full upon the earlier of (a) the first anniversary of the grant, (b) the issuer’s next annual meeting, or (c) a change of control as defined in the Issuer’s 2025 Equity Incentive Plan (footnote F1).
• Timeliness: Form 4 filed 2026-06-18 for a 2026-06-16 transaction — appears timely (within the usual 2-business-day reporting window).

Context

• This was an equity award (derivative grant), not a market purchase or sale. Such awards are commonly used for director compensation and do not by themselves signal buying or selling intent in the open market.
• For retail investors, awards are routine; purchases can be more indicative of personal bullish conviction, while awards mainly reflect company compensation practices.